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Abstract
Introduction: The duration of  action of  sub-arachnoid block is short, and one of  the ways to overcome this is the use of  oral 
clonidine.
Methods: 108 patients of  ASA I and II, aged 18 to 65 years undergoing lower abdominal surgeries under spinal anaesthesia 
were randomized into three groups.. Control group A (n=36) no oral clonidine pre-medication, Group B (n=36) and group C 
(n=36) received 100 μg and 200 μg of  oral clonidine pre-medication respectively, 1hr before spinal anaesthesia. Haemodynamic 
parameters were recorded. Sensory block, degree of  motor blockage, and sedation were assessed.
Results: Clonidine prolonged the mean duration of  motor block by 189.98±26.93 min (100μg) and 191.89±28.13 min (200μg) 
compared to 117.92±25.13 min in the control group p<0.05. The mean duration of  analgesia was 188.19±35 min (100μg) 
and194±24.58 min (200μg) in the clonidine groups compared to 115.89±26.66 min in control group p<0.05. All the patients 
were awake in the control group while 71.43% and 100% were drowsy in groups B and C respectively.
Conclusion: Oral clonidine produces better clinical effects on the onset and duration of  Bupivacaine spinal anaesthesia.
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Regional anaesthesia, particularly spinal anaesthesia is a 
popular anaesthetic technique because of  its simplicity, ef-
ficacy and safety. Edomwonyi et al reported that neuraxial 
block for prostatectomy gained overwhelming popularity 
in their institution1. However one of  the problems of  sin-
gle shot spinal anaesthesia remains the limited duration 
of  anaesthesia, even with the use of  bupivacaine which 
is a long acting local anaesthetic agent. Various methods 
have been used to prolong the duration of  action of  local 
anaesthetics when used for sub-arachnoid block.
Such methods include the addition of  drugs like ket-
amine, magnesium sulphate, neostigmine, clonidine and 
opioids to local anaesthetic agents2.
Alpha-adrenergic mechanism of  analgesia has been ex-
ploited for more than 100years3. Alpha2 adrenergic ago-
nists are routinely used in the treatment of  hypertension 
as they reduce central sympathetic outflow and modulate 
pre-synaptic transmitter release3. They also have hypnotic
effects4. Alpha2-adenoceptors are located on primary af-
ferent terminals (both at the peripheral and spinal end-
ings). Neurons in the superficial laminae of  the spinal 
cord and within several brainstem nuclei have been impli-
cated in analgesia4.
Clonidine ,an α2 adrenergic agonist produces analgesia in 
humans at spinal and supra-spinal sites of  action5,6. The 
drug has been demonstrated to inhibit neurotransmission 
of  both A delta and C nervefibers which mediate pin-
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prick, surgical pain, and tourniquet pain7,8. Gaumann et 
al have shown that clonidine enhances the effect of  lido-
caine on C-fibers action potential9.
Clonidine can be administered systemically, epidurally 
and intrathecally. Oral administration of  clonidine results 
in virtually complete absorption and peak plasma concen-
tration occurs 1-3 hours after administration5. The drug is 
highly lipid soluble easily crosses the blood-brain barrier 
and therefore may interact with α-adrenergic receptors 
at spinal and supraspinal sites within the central nervous 
system10. Several studies have been done to evaluate the 
effects of  oral clonidine when used as a pre-medicant be-
fore administering spinal anaesthesia3,11,12,13,14.
The aim of  this study was to evaluate if  a dose-related ef-
fect exists when two different doses of  oral clonidine are 
administered as a pre-medicant in the enhancement of  
bupivacaine spinal anaesthesia, to compare the haemody-
namic effects of  such doses and to evaluate the sedative 
effect of  oral clonidine.
Material and methods
The prospective randomized, double blind controlled 
study was approved by institution ethical review commit-
tee and consisted of  108 consenting ASA I and II pa-
tients who were randomized into three groups. Patients 
with bleeding disorders, neurological disorders, previous 
history of  adverse reaction to bupivacaine and clonidine, 
and, patients on anti-hypertensive therapy were excluded 
from the study. After detailed examination , the patients 
between ages 18 and 65 years undergoing lower abdomi-
nal or lower limbs surgeries under spinal anaesthesia were 
assigned into three groups.
The control group A (n=36) had no clonidine pre-medi-
cation while groups B (n=36) and C (n=36) received 100 
μg and 200 μg of  oral clonidine one hour before spinal 
anaesthesia respectively.
Using a multiparameter patient monitor, the heart rate 
(HR), systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), mean arterial pressure (MAP) and arterial 
oxygen saturation were measured non-invasively. The pa-
rameters were recorded before pre-medication with oral 
clonidine, at the time spinal anaesthesia was given (zero 
minute) and at 30 min after anaesthesia.
Sedation score was assessed using a four point scale 
(1=Awake, 2=Drowsy but responsive to verbal stimulus, 
3=Drowsy but arousable to touch, 4=unarousable)5. An 
intravenous line was secured using a 16-gauge cannula 
and each patient was pre-loaded with 15ml/kg of  normal 
saline over 20 minutes. Patients were then placed in the 
sitting position. Using aseptic technique, skin infiltration 
was done using 1% lidocaine and lumbar puncture was 
performed using a 25G Whitacre spinal needle at L2/L3 
or L3/L4 intervertebral space. Once free flow of  cere-
brospinal fluid was obtained, 15mg of  0.5% heavy bu-
pivacaine (Myungmoon Pharm. Co, LTD), was injected. 
Haemodynamic parameters were monitored every 2 min 
initially for the first ten minutes, then every 5 min until 
end of  surgery. Hypotension was defined as reduction 
in systolic blood pressure by 25% below pre-anaesthetic 
value or decreased systolic pressure below 90mmHg and 
was noted if  it occurred and treated with rapid infusion 
of  normal saline, oxygen administration, and ephedrine 
in 3mg bolus doses titrated to effect. Heart rates less than 
50 beats per min were treated with titrated doses of  atro-
pine 0.6mg as required.
The level of  sensory anaesthesia was assessed in the 
midclavicular line bilaterally using loss of  sensation to 
pinprick with a 21G needle. Response to pinprick was 
studied every 5minutes for 30 minutes after the injection 
of  the local anaesthetic. Onset of  anaesthesia was con-
sidered as appearance of  sensory block at L1. The degree 
of  motor block was assessed at 2 minutes and then at 5 
minutes interval for 20 minutes, using a modified Brom-
age scale ( 0 = no motor block, 1=inability to raise the 
extended legs, 2= inability to flex the knees, 3= inability 
to flex the ankle joints). Assessment was not carried out 
during surgery but was continued after surgery, every 30 
minutes until full recovery. The duration of  analgesia was 
considered as time between onset and time when sensory 
level weaned off  to L1.
Post-operatively in the recovery room the total duration 
of  sensory and motor block was noted.
Haemodynamicaly stable patients with sensory level low-
er than L1 and ability to lift both lower limbs were dis-
charged to the ward.
Data analysis
The data generated were presented as means and standard 
deviations, proportions and percentages as appropriate. 
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Statistical analyses were done using computer software 
package Excel 2007 version. Means were compared using 
Student’s t-test for 2 groups or ANOVA for 3 groups. 
Categorical data were compared with Chi-square test. P 
value ≤ 0.05 was considered statistically significant.
Results
All the patients in the three groups had comparable de-
mographic characteristics (Table 1).
Table II show the haemodynamic variables at rest, before 
oral clonidine was administered, at zero minute, that is, 
before spinal anaesthesia was given and at thirty minutes 
after spinal anaesthesia. There were no significant differ-
ences in the variables between the three groups at rest 
before oral clonidine was given. The mean HR at zero 
minute was lower in the clonidine groups than the control 
group but this was only statistically significant when the 
control group was compared with the 200μg clonidine 
group (p=0.05) . 
The table also shows haemodynamic measurements thirty 
minutes after spinal anaesthesia. The mean HR in group 
B (100μg) and group C (200 μg) were significantly lower 
than the control group, p= 0.05 and p=0.024 respectively 
(Table III). There was no difference in the mean HR be-
tween the clonidine groups p= 0.307(Table III).
Table I: Demographic characteristics of surgical patients given oral clonidine  
 


















































Values are mean±SD 
No significant differences among groups     
African Health Sciences Vol 18 Issue 4, December, 20181285
The mean SBP, DBP and MAP of  the patients in group C 
(200μg) group were significantly lower than those of  the 
control group p= 0.000, 0.001 and 0.000 respectively (Ta-
ble III). The SBP, DBP and MAP of  the 200μg clonidine 
were also significantly lower than those of  the group B 
(100μg) p= 0.000 for each variable (Table III).
Table IV shows the absolute degree of  change of  the 
haemodynamic parameters of  all the groups from the 
baseline. In the control group A the mean HR significant-
ly increased from the baseline (p = 0.01), the mean SBP 
was significantly reduced from the baseline (p= 0.028) 
while the change in the parameters of  mean DBP and 
MAP from the baseline were not statistically significant 
(p = 1.101 and 0.103 respectively).
The absolute degree of  haemodynamic changes of  group 
B (100μg of  oral clonidine) from the baseline showed sig-
nificant reductions in the mean HR (p= 0.000), SBP (p= 
0.000), DBP ( p= 0.003) and MAP (p= 0.017).
The 200 μg oral clonidine group (group C) showed sig-
nificant reductions in SBP, DBP and MAP at 30 minutes 
(p= 0.000 respectively) as shown in Table IV. However 
there was no statistically significant reduction in mean 
HR (p=0.133)
Table II: Heamodynamic parameters of patients at rest (baseline), zero minute 
before instituting spinal and 30 minutes after spinal anaesthesia. 
                                                    At rest                              Before spinal                                 30 min 
HR       A                                    82.5±15.6                        97.5±22.7                                      92±19.8 
            B                                    87.1±88                            96.6±8.8                                        83.9±19.9 
            C                                    91.9±19.8                         87.0±12                                         84.6±13.7 
            P value                         1.801                                 0.164                                              0.044 
SBP     A                                    135±6.7                            136.7±17.7                                    126.4±17.2 
            B                                    139.1±17.1                      148.3±22.2                                    130.1±11.6 
            C                                    121.5±11.6                      120.3±10                                       106.8±8.8 
            P value                         0.258                                 0.584                                             0.065 
 DBP    A                                   76.8±14.5                         76.8±14.5                                     70.5±148 
            B                                    81±11                               81±11                                            72.1±12 
            C                                    70.6±8.3                           70.6±8.3                                       62.3±8.7 
            P value                         0.760                                 0.760                                             0.352                                                                                                                                                                                                 
MAP   A                                    98.4±13.5                         98.8±14.4                                     92.3±15.1 
            B                                    106.3±31.4                       105.3±14.8                                  93.4±10.7 
            C                                    90.7±7.6                           89.6±9.6                                       78.7±8 
            P value                         1.012                                 0.717                                             0.112 
 
N = 36 patients in each group  
GROUP A = No clonidine  
GROUP B = 100µg 
GROUP C = 200 µg 
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Onset of  Sensory Block (Table V)
The onset of  sensory block was significantly faster in 
the clonidine groups than the control group, It was 6.69 
±2.55 mins in the control group compared to 2.19 ±0.7 
mins in the 100μg clonidine group (p= 0.000) and 2.08 
±0.28mins in the 200 μg group (p= 0.000) . There was no 
significant difference in onset of  sensory block between 
the clonidine groups (p= 0.348)
Onset of  Motor Block (Table V)
The onset of  motor block was significantly faster in the 
clonidine groups than the control group.
It was 2.05 ±0.41mins in the control group compared to 
1.02 ±0.16 mins in the 100 μg clonidine group (p= 0.000) 
and 1.00 ±0.00 mins in the 200 μg group (p= 0.0000). 
There was no significant difference in onset of  motor 
block between the clonidine groups (p= 0.317) .
Table III: Comparing P values of haemodynamic parameters of groups at rest, 
before spinal (zero minutes) and 30 minutes. 
                                            P value  at rest                P value before  spinal                 P value  30 min 
HR        A vs B                              0.077                             0.809                                       0.005                                
             B vs C                              0.001                             0.000                                       0.307 
             A vs C                              0.000                             0.005                                       0.024 
 
 SBP     A vs B                              0.146                             0.000                                       0.196 
             B vs C                              0.000                             0.000                                       0.000 
             A vs C                              0.000                             0.000                                       0.000 
 
DBP     A vs B                              0.000                              0.000                                      0.513 
            B vs C                               0.158                             0.000                                      0.000 
            A vs C                               0.259                             0.009                                       0.001 
 
MAP   A vs B                               0.000                             0.006                                       0.667 
            B vs C                               0.002                             0.000                                       0.000 
            A vs C                               0.000                             0.000                                       0.000                                                                                                                                                                                             
 
Table IV: Haemodynamic changes of the groups from baseline 
to 30 minutes after spinal anaesthesia 
                                        Baseline                       30 min                         % change                                     P value                 
A            HR              82.5±8.8                        92±19.7                            11.48                                     0.010 
              SBP             135.1±16.7                     126.4±17.2                      6.40                                       0.028 
              DBP            75.9±10.3                         70.5±14.8                       7.03                                       1.101 
              MAP            98.4±13.5                       92.3±15.1                       6.13                                       0.103 
 
B           HR                87.1±8.8                          83.9±13.7                       4.95                                        0.000 
             SBP              139.1±17.1                       130.1±11.6                    6.47                                        0.000 
             DBP              76.1±9.6                           72.1±12                         5.36                                        0.003 
             MAP            106.3±31.4                      93.4±10.7                       12.10                                      0.017 
 
C          HR               91.9±19.8                          84.6±13.7                      7.97                                        0.133 
            SBP              121.5±11.6                       106.8±8.8                       12.02                                     0.000 
            DBP             73.9±8                                62.3±8.7                         15.07                                     0.000 
            MAP            90.7±7.6                            78.7±8                             13.22                                     0.000 
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Duration of  Sensory Block (Table VI )
The duration of  sensory block was significantly longer in 
the clonidine groups than the control group. It was 115.89 
±26.66mins in the control group compared to 188.19 
±35.19mins in the 100μg clonidine group (p= 0.000) and 
194 ±24.58mins in the 200 μg group (p= 0.000). There 
was no significant difference in duration of  sensory block 
between the two clonidine groups (p=0.138).
Duration of  Motor Block (Table VI)
The duration of  motor block was also significantly longer 
in the clonidine groups than the control group. It was 
117.92 ± 25.13 mins in the control group compared to 
189.94 ±26.93 mins in the 100 μg clonidine group (p= 
0.000) and 191.89 ±28.13 mins in the 200 μg clonidine 
group (p= 0.000). There was no difference in duration 
of  motorblock between the two clonidine groups (p= 
0.678).
Table V: Comparison of Onset of Sensory and Motor Block 
amongst the Groups (Mean ± SD) 
 
Groups Sensory Block (mins)                    Motor Block (mins) 
Group A 6.69 +2.55                                          2.05 + 0.41 
 
Group B 2.19 + 0.7                                           1.02 + 0.16 
 
Group C 2.08 + 0.28                                         1.0 + 0.0 
 
 
Sensory block p value                     Motor block p value 
GROUP A vs B               0.000     0.000 
GROUP A vs C                    0.000     0.000 
GROUP B vs C                    0.348   0.317 
 
 
Table VI: Comparison of Duration of Sensory and Motor 
                        Block amongst the groups (Mean ± SD) 
 
GROUPS Sensory Block(Mins)        Motor Block (Mins) 
Group A 115.89 + 25.66                          117.92+25.13 
Group B 188.19 + 35.19                          189.94+26.93 
Group C 194.28 + 24.58                          191.89+28.13 
 
Sensory block p value                   Motor block p value 
GROUP A vs B  0.000     0.000 
GROUP A vs C  0.000     0.000 
GROUP B vs C  0.138     0.678 
  
Sedation Score
Sedation score showed that the patients in the cloni-
dine groups were more sedated than those in the control 
group. All the patients (100%) in the control group were 
awake, while in the 100μg clonidine group 28.57% were 
awake and 71.43% were drowsy but responded to verbal 
stimulation. In the 200μg clonidine group, all the patients 
i.e. 100% were drowsy but responded to verbal stimulus 
(Table VII).
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Table VII: Degree of Sedation among the Groups 
 
GROUP 1 (%)  2(%) 3(%) 4(%) 
GROUP A 100 0 0 0 
GROUP B 28.57 71.43 0 0 
GROUP C 0 100 0 0 
 
 1: Awake   
 2: Drowsy but responsive to verbal stimulus    
 3: Drowsy but arousable to touch    
 4: Unarousable 
Discussion
The study showed that patients pre-medicated with 100μg 
clonidine had a 4.95% fall in heart rate at thirty minutes 
when compared to the base line, which was statistically 
significant(p=0.000). Group C (200μg) also had a 7.95% 
fall in heart rate at thirty minutes when compared to the 
baseline (p=0.133), while the control group had an in-
crease in heart rate of  11.48% from the baseline when 
compared to thirty minutes which was statistically signif-
icant (p=0.010). The increase in heart rate in the control 
group was probably due to the lack of  the net effects of  
clonidine which is to down-regulate, or at least reduce the 
sympathetic response. The result of  the heart rate at zero 
minute and thirty minutes in group B (100μg) was similar 
to studies conducted by Swati et al15 . Liu et al also report-
ed a significant fall in heart rate in patients pre-medicated 
with 200μg of  oral clonidine5. All the groups had a statis-
tically significant fall in systolic blood pressure from the 
baseline, group A (6.40%), group B (6.47%) and group 
C(12.02%) probably due to the additive effects of  spinal 
anaesthesia. These findings were similar to the study by 
Liu et al2. Group B (100μg) and group C (200μg) of  oral 
clonidine had significant decrease in DBP and MAP, from 
the baseline (p<0.05). This decrease was not seen in the 
control group A (p>0.05).
Various studies have shown that oral clonidine, when used 
as pre-medication before spinal anaesthesia has effects on 
the duration of  sensory and motor block3,5,15,16 . In the 
study by Swati et al15 the duration was prolonged by 30-
40 minutes. In all the previous studies mentioned above, 
a single dose of  clonidine was used but in our study two 
different doses of  clonidine were used and the aim was 
to establish if  there was a dose related effect on the onset 
and duration of  sensory and motor block.
The onset of  sensory block at L1 was faster in the clon-
idine groups when compared with the control group. ( 
TableV). This was comparable with the study of  Aftab et 
al3 .However, when the clonidine groups were compared, 
the difference in time of  onset at L1 was not statistical-
ly significant p>0.05. Similarly the onset of  motor block 
was faster in the clonidine groups than the control group 
(Table V) .This result was different from that of  Afteb et 
al who reported that the onset of  motor block was simi-
lar between the control group and patients pre-medicated 
with 150μg of  oral clonidine3.
Liu et al5 and Harbhej et al17 also found that 200μg of  
oral clonidine prolonged the duration of  lignocaine and 
tetracaine spinal anaesthesia respectively. The study of  
Otalet al12 compared the dose-related effects using three 
different doses of  oral clonidine 75μg, 150μg and 300μg 
on tetracaine spinal anaesthesia. The dose response data 
suggested that the prolongation of  sensory block by oral 
clonidine seems to plateau at a dose of  150μg because 
regression to L1 dermatome was increased by 45% with 
75μg, 92% with 150μg and 76% with 300μg of  oral clon-
idine respectively. In this study, the result of  the com-
parison of  the sensory and motor blocks of  the control 
group to the clonidine groups is similar to other studies 
mentioned above5,12,17. The result shows a statistical sig-
nificant increase in duration of  sensory and motor blocks 
in the clonidine groups when compared to the control 
group (p<0.05). Interestingly, there were no differences 
in the duration of  sensory and motor blocks between the 
two clonidine groups in this study. Comparing these re-
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sults with those of  Ota et al12 ,who concluded that the 
effect of  oral clonidine on duration of  tetracaine spinal 
anaesthesia seems to plateau at 150μg, this study shows 
that the effect of  oral clonidine on duration of  sensory 
and motor block in bupivacaine spinal anaesthesia is in 
the dose range of  100-200μg. This is because these dos-
ages prolonged sensory and motor blocks almost equally.
The mechanisms of  how oral clonidine affects sensory 
and motor block remains unclear, however direct inhibi-
tion of  A alpha motor fibers, C nerve fibers8 and augmen-
tation of  intrathecal local anaesthetic effects19 has been 
postulated to play a role in the effects of  oral clonidine.
Butterworth and Strichartz8 demonstrated that analgesia 
after neuraxial administration of  α2-adrenergic agonists 
may, in fact, result from direct inhibition of  impulse con-
duction in the Aα and C fibers. However unlike the tradi-
tional local anaesthetics, clonidine produces greater inhi-
bition of  C fibers than Aα fibers20. Some of  the analgesic 
efficacy of  α2 –adrenergic agonists following regional in-
jection may result from a local anaesthetic –type of  action 
on Aα and, especially, C fibers. In this study the duration 
of  analgesia in the control group was 115.89±26.66 min 
while that of  the clonidine groups were 188.14±35.19 
min (100 μg) and 194±24.58 min (200 μg) respectively 
which was statistically significant p=0.00 this was similar 
to that of  several studies3,14,15. The potent analgesic prop-
erty of  clonidine is because it acts at spinal and supra-
spinal sites, it has a non-opioid mechanism of  analgesic 
action on the medullospinal noradrenergic pathway mod-
ulating spinal nociceptive processing and the α2-adrener-
gic receptor that are strategically located on the dorsal 
horn neurons of  the spinal cord where it can either in-
hibit the release of  nociceptive neurotransmitters such as 
substance ‘P’ or calcitonin gene related peptide.14 Anoth-
er analgesic mechanism is by the synergistic interaction 
between α2-adrenergic agonist and opiates in the spinal 
cord.14
Sedation has been shown to increase patient’s satisfaction 
during regional anaesthesia21 and may be considered as 
a means to increase the patient’s acceptance of  regional 
anaesthetic techniques.
For surgery under regional anaesthesia, sedation is a valu-
able tool to make it more convenient for the patient, the 
anaesthetist, and the surgeon. In this study, the incidence 
of  sedation with 100μg of  oral clonidine was 71.43% 
while the control group had zero percent. This is compa-
rable to the pattern observed in the study by Swati et al 
in which the incidence of  sedation using 100mcg of  oral 
clonidine was 64% while the control group had zero per-
cent15. However the incidence of  sedation in the 200μg 
of  oral clonidine was 100%, suggesting that the incidence 
of  sedation had a dose response effect. Liu et al also re-
ported that the incidence of  sedation was greater in the 
group premedicated 200μg of  oral clonidine and was in 
agreement with previous dose-response studies of  oral 
clonidine22,23. Clonidine produces a dose-dependent se-
dation over the dose range of  50-900μg of  rapid onset 
(20minute) regardless of  the route of  administration4.
Conclusion
The study demonstrated that pre-medication of  healthy 
patients with oral clonidine one hour prior to bupivacaine 
spinal anaesthesia gave a faster onset andlonger duration 
of  spinal anaesthesia. Furthermore, it also provided a dis-
tinct advantage because of  its sedative property.
Recommendations
Based on the findings in this study, it is recommended 
that the use of  oral clonidine pre-medication before bu-
pivacaine spinal anaesthesia in adults is desirable.
Opioids which are one of  the commonest agents added 
to local anaesthetic to prolong its duration is not always 
available in tertiary health centres and hardly available in 
non-specialist hospitals. Therefore, we advocate the use 
of  oral clonidine as a pre-anaesthetic medication in all 
healthy adult surgical patients for elective surgical pro-
cedure involving the lower abdominal and lower limbs 
under bupivacaine spinal anaesthesia because it prolongs 
spinal anaesthesia, provides desirable sedative effects and 
a tolerable peri-operative heamodynamic profiles.
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